Xiangyi Wang


Xiangyi Wang obtained her MSc in Biomedical Research from Imperial College London (UK) in October 2019. During her master study she worked on exploring novel therapeutic treatments on human cancers including breast cancers and glioblastoma. She joined the Vogel lab as a researcher in 2020. Her current research focuses on investigating small RNA in Fusobacterium during host-pathogen interaction.